October was a relatively quiet month for psychedelic research. Nonetheless, we still gained some valuable new insights into the world of psychedelics. Natural language processing (NLP) was used to successfully predict clinical outcomes using data from a trial exploring psilocybin on treatment-resistant depression (TRD); but only after the first psilocybin session had taken place.


Previous articleBREAKING: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM
Next articleCOMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights